-
When health researchers make headlines, it’s often for a sensational project – like manipulating genes to create a baby. But others are examining broader…
-
A company has priced its test for mutations linked to breast and ovarian cancer at $249 — far less than the thousands of dollars another firm charges. But is there a downside for the worried well?
-
Genetic profiling of cancer cells can help guide treatment, but such profiles can be ambiguous. Results would be more accurate if all labs tested normal cells from each patient, too.